Effect of tianeptine on depressed tinnitus patients

Soo Min Hwang, Sae Hee Lim, Dong Ju Oh, Sung Kyun Kim, Hak Hyun Jung, Gi Jung Im

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and Objectives: Tianeptine is a tricyclic antidepressant that has a novel pharmacological property: it increases the reuptake of 5-hydroxytryptamine. Recent studies have reported that the prevalence of depression is greater in patients with tinnitus than in control subjects who do not have tinnitus. The purpose of this study was to assess the efficacy of tianeptine for the relief of tinnitus, especially in patients with depressive mood. Subjects and Methods: Among a total of 52 tinnitus patients, 15 had depressive mood. The depressed tinnitus patients were prescribed Stablon® 12.5 mg once daily for 1 month without any other drug. We assessed the severity of tinnitus, level of depression, and the quality of sleep in these patients by using the Tinnitus Handicap Inventory (THI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Hearing impairment and severity of tinnitus were measured with pure tone audiometry, speech audiometry, and tinnitograms. These evaluations were conducted before and after medication treatment. Results: For the 15 depressed tinnitus patients, THI scores significantly correlated with BDI and PSQI scores prior to medication treatment. These results showed that the discomfort of tinnitus was closely related to depression and sleep disorder. After medication treatment, THI and BDI scores significantly decreased, indicating that tinnitus and depression improved. However, no significant alteration in PSQI score was observed, indicating that there was no improvement in sleep quality. Conclusions: In the treatment of depressed tinnitus patients, tianeptine might be an efficient drug to treat both tinnitus and depression. However, tianeptine is unlikely to improve the quality of sleep in these patients.

Original languageEnglish
Pages (from-to)90-96
Number of pages7
JournalJournal of audiology and otology
Volume20
Issue number2
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

tianeptine
Tinnitus
Depression
Sleep
Equipment and Supplies

Keywords

  • Depression
  • Sleep disorder
  • Tianeptine
  • Tinnitus

ASJC Scopus subject areas

  • Sensory Systems
  • Speech and Hearing

Cite this

Effect of tianeptine on depressed tinnitus patients. / Hwang, Soo Min; Lim, Sae Hee; Oh, Dong Ju; Kim, Sung Kyun; Jung, Hak Hyun; Im, Gi Jung.

In: Journal of audiology and otology, Vol. 20, No. 2, 01.01.2016, p. 90-96.

Research output: Contribution to journalArticle

Hwang, Soo Min ; Lim, Sae Hee ; Oh, Dong Ju ; Kim, Sung Kyun ; Jung, Hak Hyun ; Im, Gi Jung. / Effect of tianeptine on depressed tinnitus patients. In: Journal of audiology and otology. 2016 ; Vol. 20, No. 2. pp. 90-96.
@article{cc45b473a5b74e0aae2d7707267ff25f,
title = "Effect of tianeptine on depressed tinnitus patients",
abstract = "Background and Objectives: Tianeptine is a tricyclic antidepressant that has a novel pharmacological property: it increases the reuptake of 5-hydroxytryptamine. Recent studies have reported that the prevalence of depression is greater in patients with tinnitus than in control subjects who do not have tinnitus. The purpose of this study was to assess the efficacy of tianeptine for the relief of tinnitus, especially in patients with depressive mood. Subjects and Methods: Among a total of 52 tinnitus patients, 15 had depressive mood. The depressed tinnitus patients were prescribed Stablon{\circledR} 12.5 mg once daily for 1 month without any other drug. We assessed the severity of tinnitus, level of depression, and the quality of sleep in these patients by using the Tinnitus Handicap Inventory (THI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Hearing impairment and severity of tinnitus were measured with pure tone audiometry, speech audiometry, and tinnitograms. These evaluations were conducted before and after medication treatment. Results: For the 15 depressed tinnitus patients, THI scores significantly correlated with BDI and PSQI scores prior to medication treatment. These results showed that the discomfort of tinnitus was closely related to depression and sleep disorder. After medication treatment, THI and BDI scores significantly decreased, indicating that tinnitus and depression improved. However, no significant alteration in PSQI score was observed, indicating that there was no improvement in sleep quality. Conclusions: In the treatment of depressed tinnitus patients, tianeptine might be an efficient drug to treat both tinnitus and depression. However, tianeptine is unlikely to improve the quality of sleep in these patients.",
keywords = "Depression, Sleep disorder, Tianeptine, Tinnitus",
author = "Hwang, {Soo Min} and Lim, {Sae Hee} and Oh, {Dong Ju} and Kim, {Sung Kyun} and Jung, {Hak Hyun} and Im, {Gi Jung}",
year = "2016",
month = "1",
day = "1",
doi = "10.7874/jao.2016.20.2.90",
language = "English",
volume = "20",
pages = "90--96",
journal = "Journal of audiology and otology",
issn = "2384-1621",
publisher = "Korean Audiological Society",
number = "2",

}

TY - JOUR

T1 - Effect of tianeptine on depressed tinnitus patients

AU - Hwang, Soo Min

AU - Lim, Sae Hee

AU - Oh, Dong Ju

AU - Kim, Sung Kyun

AU - Jung, Hak Hyun

AU - Im, Gi Jung

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background and Objectives: Tianeptine is a tricyclic antidepressant that has a novel pharmacological property: it increases the reuptake of 5-hydroxytryptamine. Recent studies have reported that the prevalence of depression is greater in patients with tinnitus than in control subjects who do not have tinnitus. The purpose of this study was to assess the efficacy of tianeptine for the relief of tinnitus, especially in patients with depressive mood. Subjects and Methods: Among a total of 52 tinnitus patients, 15 had depressive mood. The depressed tinnitus patients were prescribed Stablon® 12.5 mg once daily for 1 month without any other drug. We assessed the severity of tinnitus, level of depression, and the quality of sleep in these patients by using the Tinnitus Handicap Inventory (THI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Hearing impairment and severity of tinnitus were measured with pure tone audiometry, speech audiometry, and tinnitograms. These evaluations were conducted before and after medication treatment. Results: For the 15 depressed tinnitus patients, THI scores significantly correlated with BDI and PSQI scores prior to medication treatment. These results showed that the discomfort of tinnitus was closely related to depression and sleep disorder. After medication treatment, THI and BDI scores significantly decreased, indicating that tinnitus and depression improved. However, no significant alteration in PSQI score was observed, indicating that there was no improvement in sleep quality. Conclusions: In the treatment of depressed tinnitus patients, tianeptine might be an efficient drug to treat both tinnitus and depression. However, tianeptine is unlikely to improve the quality of sleep in these patients.

AB - Background and Objectives: Tianeptine is a tricyclic antidepressant that has a novel pharmacological property: it increases the reuptake of 5-hydroxytryptamine. Recent studies have reported that the prevalence of depression is greater in patients with tinnitus than in control subjects who do not have tinnitus. The purpose of this study was to assess the efficacy of tianeptine for the relief of tinnitus, especially in patients with depressive mood. Subjects and Methods: Among a total of 52 tinnitus patients, 15 had depressive mood. The depressed tinnitus patients were prescribed Stablon® 12.5 mg once daily for 1 month without any other drug. We assessed the severity of tinnitus, level of depression, and the quality of sleep in these patients by using the Tinnitus Handicap Inventory (THI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Hearing impairment and severity of tinnitus were measured with pure tone audiometry, speech audiometry, and tinnitograms. These evaluations were conducted before and after medication treatment. Results: For the 15 depressed tinnitus patients, THI scores significantly correlated with BDI and PSQI scores prior to medication treatment. These results showed that the discomfort of tinnitus was closely related to depression and sleep disorder. After medication treatment, THI and BDI scores significantly decreased, indicating that tinnitus and depression improved. However, no significant alteration in PSQI score was observed, indicating that there was no improvement in sleep quality. Conclusions: In the treatment of depressed tinnitus patients, tianeptine might be an efficient drug to treat both tinnitus and depression. However, tianeptine is unlikely to improve the quality of sleep in these patients.

KW - Depression

KW - Sleep disorder

KW - Tianeptine

KW - Tinnitus

UR - http://www.scopus.com/inward/record.url?scp=85006382018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006382018&partnerID=8YFLogxK

U2 - 10.7874/jao.2016.20.2.90

DO - 10.7874/jao.2016.20.2.90

M3 - Article

VL - 20

SP - 90

EP - 96

JO - Journal of audiology and otology

JF - Journal of audiology and otology

SN - 2384-1621

IS - 2

ER -